Section Arrow
Quote
CDT.NASDAQ
- Conduit Pharmaceuticals Inc
Quotes are at least 15-min delayed:2025/07/21 15:41 EDT
Regular Hours
Last
 2.1109
+0.0009 (+0.04%)
Day High 
2.1304 
Prev. Close
2.11 
1-M High
3.05 
Volume 
133.25K 
Bid
2.11
Ask
2.13
Day Low
1.94 
Open
2.06 
1-M Low
2.05 
Market Cap 
5.07M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.31 
20-SMA 2.46 
50-SMA 3.4 
52-W High 622.5 
52-W Low 0.441 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-255.60/--
Enterprise Value
5.18M
Balance Sheet
Book Value Per Share
1.12
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TNFATNF Pharmaceuticals Inc.0.1175+0.03+34.29%-- 
PMNProMIS Neurosciences1.01+0.5699+129.49%5PE
NCNANuCana plc0.0514+0.0037+7.76%-- 
SABSSAB Biotherapeutics2.79+0.22+8.56%-- 
RXRXRecursion Pharmaceuticals6.4015+0.5615+9.61%-- 
Quotes are at least 15-min delayed：2025/07/21 15:41 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceuticalcompanies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.